|
SRFBP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.79555999999526E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.815100E-03 |
| Normal-vs-Stage2 |
6.996300E-02 |
| Normal-vs-Stage3 |
2.17109999999243E-05 |
| Normal-vs-Stage4 |
2.5341999998485E-07 |
| Stage1-vs-Stage2 |
9.871200E-01 |
| Stage1-vs-Stage3 |
4.822400E-02 |
| Stage1-vs-Stage4 |
4.420000E-03 |
| Stage2-vs-Stage3 |
2.849000E-01 |
| Stage2-vs-Stage4 |
9.558400E-02 |
| Stage3-vs-Stage4 |
3.814000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.27240000000495E-05 |
| Normal-vs-AfricanAmerican |
6.32530000044262E-07 |
| Normal-vs-Asian |
2.098600E-01 |
| Caucasian-vs-AfricanAmerican |
2.115800E-02 |
| Caucasian-vs-Asian |
8.540600E-01 |
| AfricanAmerican-vs-Asian |
2.710800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.59504999999172E-05 |
| Normal-vs-Female |
5.377100E-04 |
| Male-vs-Female |
4.317800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.582300E-04 |
| Normal-vs-Age(41-60Yrs) |
2.950400E-04 |
| Normal-vs-Age(61-80Yrs) |
1.558970E-04 |
| Normal-vs-Age(81-100Yrs) |
1.242300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.779850E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.897370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.212200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.714400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.248800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.362400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.917000E-01 |
| Normal-vs-Grade 2 |
1.157930E-02 |
| Normal-vs-Grade 3 |
4.81080000003242E-06 |
| Normal-vs-Grade 4 |
3.34059999662628E-08 |
| Grade 1-vs-Grade 2 |
8.519000E-01 |
| Grade 1-vs-Grade 3 |
2.406400E-01 |
| Grade 1-vs-Grade 4 |
3.653500E-02 |
| Grade 2-vs-Grade 3 |
1.685990E-02 |
| Grade 2-vs-Grade 4 |
4.016400E-04 |
| Grade 3-vs-Grade 4 |
2.241600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.710180E-01 |
| Normal-vs-ccB subtype |
4.16700000005488E-06 |
| ccA subtype-vs-ccB subtype |
7.54560000000293E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.784600E-04 |
| Normal-vs-N1 |
2.361100E-03 |
| N0-vs-N1 |
2.629000E-01 |
|
|
